Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.48% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
STAG Industrial
STAG
$7.12B
| $20.2M | 0.02% |
638,600
+300,500
| +89% | +$9.21M |
|
|
BBL
1002
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $20.1M | 0.02% |
428,500
+149,300
| +53% | +$6.57M |
|
|
LFC
1003
DELISTED
China Life Insurance Company Ltd.
LFC
| $20.1M | 0.02% |
1,454,735
+41,817
| +3% | +$536K |
|
1004
KNOT Offshore Partners
KNOP
$362M
| $20.1M | 0.02% |
1,014,861
+318,950
| +46% | +$6.15M |
|
|
SNV
1005
DELISTED
Synovus
SNV
| $20.1M | 0.02% |
512,618
+454,318
| +779% | +$16.7M |
|
1006
Sabra Healthcare REIT
SBRA
$5.15B
| $20.1M | 0.02% |
+939,979
| New | +$21M |
|
|
XLNX
1007
DELISTED
Xilinx Inc
XLNX
| $20M | 0.02% |
204,499
-657,105
| -76% | -$61.7M |
|
1008
ResMed
RMD
$32.8B
| $19.9M | 0.02% |
128,546
+121,446
| +1,711% | +$17.5M |
|
1009
Sonos
SONO
$1.86B
| $19.9M | 0.02% |
1,272,698
+1,255,798
| +7,431% | +$17.5M |
|
1010
Kemper
KMPR
$1.56B
| $19.9M | 0.02% |
256,146
+16,400
| +7% | +$1.22M |
|
1011
Flex
FLEX
$45.9B
| $19.8M | 0.02% |
2,084,724
-3,671,077
| -64% | -$31.7M |
|
1012
Mercado Libre
MELI
$92.7B
| $19.8M | 0.02% |
34,600
-49,400
| -59% | -$27.3M |
|
1013
Crown Holdings
CCK
$13.1B
| $19.8M | 0.02% |
+272,600
| New | +$19.4M |
|
|
DHIL
1014
DELISTED
Diamond Hill
DHIL
| $19.8M | 0.02% |
140,733
-3,200
| -2% | -$448K |
|
|
BCOV
1015
DELISTED
Brightcove, Inc.
BCOV
| $19.7M | 0.02% |
2,272,251
+39,419
| +2% | +$370K |
|
1016
Camtek
CAMT
$8.13B
| $19.7M | 0.02% |
1,822,700
+28,020
| +2% | +$292K |
|
1017
Credit Acceptance
CACC
$5.99B
| $19.7M | 0.02% |
44,488
-10,000
| -18% | -$4.41M |
|
|
AHT
1018
Ashford Hospitality Trust
AHT
$19.8M
| $19.6M | 0.02% |
7,041
+606
| +9% | +$1.7M |
|
|
JHG
1019
DELISTED
Janus Henderson
JHG
| $19.6M | 0.02% |
803,312
-487,788
| -38% | -$11.6M |
|
|
FLIC
1020
DELISTED
First of Long Island Corp
FLIC
| $19.6M | 0.02% |
780,281
+72,300
| +10% | +$1.72M |
|
|
UMPQ
1021
DELISTED
Umpqua Holdings Corp
UMPQ
| $19.5M | 0.02% |
1,099,588
+460,700
| +72% | +$7.62M |
|
|
CNR
1022
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $19.4M | 0.01% |
2,281,700
-249,300
| -10% | -$1.75M |
|
1023
Veeco
VECO
$3.26B
| $19.2M | 0.01% |
1,309,604
+247,901
| +23% | +$3.38M |
|
1024
Leggett & Platt
LEG
$1.29B
| $19.2M | 0.01% |
+377,533
| New | +$18.5M |
|
|
LBAI
1025
DELISTED
Lakeland Bancorp Inc
LBAI
| $19.2M | 0.01% |
1,103,400
+77,100
| +8% | +$1.27M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.